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In humans, two splice variants of the glucocorticoid receptor (GR) exist: the canonical a-isoform, and the
b-isoform, which has been shown to have a dominant-negative effect on hGRa. Previously, we have
established the occurrence of a GR b-isoform in zebraﬁsh, and in the present study we have investigated
the functional role of the zebraﬁsh GRb (zGRb). Reporter assays in COS-1 cells demonstrated a dominant-
negative effect of zGRb but no such effect was observed in zebraﬁsh PAC2 cells using induction of the
fk506 binding protein 5 (fkbp5) gene as readout. Subsequently, we generated a transgenic ﬁsh line with
inducible expression of zGRb. Transcriptome analysis suggested transcriptional regulation of genes by
zGRb in this line, but further validation failed to conﬁrm this role. Based on these results, its low
expression level and its poor evolutionary conservation, we suggest that the zebraﬁsh GR b-isoform does
not have a functional role in transcriptional regulation.
© 2017 Elsevier B.V. All rights reserved.1. Introduction
The glucocorticoid receptor (GR) is expressed throughout the
human body and regulates a wide variety of biological processes,
like our metabolism, growth, reproduction, vascular tone, bone
formation, immune response and brain function (Chrousos and
Kino, 2005; de Kloet et al., 2005; Heitzer et al., 2007; Revollo and
Cidlowski, 2009; Sapolsky et al., 2000; Schoneveld et al., 2004).
The GR is activated upon binding to glucocorticoid (GC) ligands, and
acts as a transcription factor, orchestrating gene expression via
DNA-binding-dependent and -independent mechanisms (Beato
and Klug, 2000, Buckingham, 2006; De Bosscher and Haegeman,
2009, Heitzer et al., 2007; Nicolaides et al., 2010; Schoneveld
et al., 2004; van der Laan and Meijer, 2008). Cloning of the hu-
man GR gene revealed the occurrence of two splice variants, named
as hGRa and hGRb, which derive from alternative usage of an
acceptor splice site within the last coding exon (exon 9, see
Suppl. Fig.1) (Encio and Detera-Wadleigh, 1991; Hollenberg et al.,
1985). The GR a-isoform (777 amino acids) is able to interact with
GCs, and represents the canonical receptor. The hGR b-isoform (742iden, The Netherlands.
l (M.J.M. Schaaf).amino acids) has a shorter LBD with a unique C-terminal 15 amino
acid sequence, which renders it unable to respond to GCs (Encio
and Detera-Wadleigh, 1991; Hollenberg et al., 1985; Kino et al.,
2009a,b).
Almost ten years after the discovery of hGRb, it was shown using
in vitro reporter assays that this isoform had a pronounced
dominant-negative inhibitory effect on hGRa’s transcriptional
properties on GRE-containing promoters (Bamberger et al., 1995;
Oakley et al., 1996, 1999). Moreover, hGRa-mediated repression of
NF-kB activity in in vitro reporter assays was also reported to be
inhibited by hGRb (Oakley et al., 1999). These ﬁndings were soon
coupled to clinical data demonstrating a positive correlation be-
tween high expression levels of the b-isoform and GC resistance of
patients suffering from immune-related disorders, like asthma
(Christodoulopoulos et al., 2000; Goleva et al., 2006; Hamid et al.,
1999; Hamilos et al., 2001; Leung et al., 1997; Sousa et al., 2000),
ulcerative colitis (Fujishima et al., 2009; Orii et al., 2002; Zhang
et al., 2005), leukemia (Koga et al., 2005; Longui et al., 2000;
Shahidi et al., 1999) and rheumatoid arthritis (Derijk et al., 2001;
Goecke and Guerrero, 2006). Further cell-based research has sup-
ported an inhibitory role for hGRb on both hGRa-induced activation
and repression of endogenous genes (MKP-1, myocilin, ﬁbronectin,
TNFa and IL6 (Goleva et al., 2006; Li, 2006; Zhang, 2005)), as well as
on hGRa-mediated regulation of cell death, proliferation and
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2007). Moreover, recent data support the notion that hGRb can
have its own intrinsic transcriptional activity. Overexpression of
zGRb has been demonstrated to attenuate NF-kB and AP-1 induc-
tion of luciferase reporter constructs (Gougat et al., 2002), as well as
GATA3-mediated activation of IL5 and IL13 promoters of luciferase
genes (Kelly et al., 2008). Additionally, transcriptome analyses of
cultured cells showed that hGRb can direct gene transcription
independently of hGRa activation (Kino et al., 2009a,b; Lewis-Tufﬁn
et al., 2007). In a recent study, overexpression of hGRb in the liver of
mice showed both GRa-dependent and -independent regulation of
gene expression by hGRb (He et al., 2016).
Despite the available data described above, the physiological
relevance of hGRb is still under debate. First, in many studies the
dominant-negative role of hGRb on hGRa’s transcriptional prop-
erties could not be conﬁrmed (Bamberger et al., 1997; Brogan et al.,
1999; Carlstedt-Duke, 1999; Gougat et al., 2002; Hecht et al., 1997;
Kelly et al., 2008; Kim et al., 2009; Taniguchi et al., 2010). Second,
hGRb’s expression levels are signiﬁcantly lower compared to those
of hGRa (Bamberger et al., 1995; de Castro et al., 1996; Oakley et al.,
1996, 1997; Pujols et al., 2002; Strickland et al., 2001). This raises
doubts about its in-vivo dominant-negative effect, since in most
studies this required transfection of a 10-M excess of hGRb
expression vector compared to hGRa (Bamberger et al., 1995;
Oakley et al., 1996, 1999). Third, the evolutionary conservation
appears to be poor. Previously, we showed that the GRb protein
sequence is only conserved between primates, and that the gene
organization required for GRb expression is present in a limited
group of placental mammals (Schaaf et al., 2008). For example,
rodents, cats, dogs and hedgehogs contain a mutation in the splice
acceptor site required for GRb expression (Otto et al., 1997; Schaaf
et al., 2008). As a result, until recently no animal model was
available for functional studies on GRb.
Remarkably, several years agowe discovered the occurrence of a
GR b-isoform in zebraﬁsh (Schaaf et al., 2008). Like its human
equivalent, the zebraﬁsh GR b-isoform differs from the a-isoform at
the C-terminus and diverges from the GRa sequence at the same
point as the human GRb. Both the human and zebraﬁsh GR b-iso-
forms exhibit the same predominantly nuclear localization, and
zGRb also acts as a dominant-negative inhibitor of zGRa-mediated
transactivation in in vitro reporter assays (Schaaf et al., 2008).
However, differences exist between these GR b-isoforms, which
demonstrates that they have evolved independently. First, the GRb-
speciﬁc C-terminal sequences are very different between zebraﬁsh
and human GRb (Schaaf et al., 2008; Yudt et al., 2003). Second, in
the human GR gene the GRb-speciﬁc sequence is located in exon 9,
whereas in the zebraﬁsh GR gene it is found in the intronic
sequence immediately downstream of exon 8 (Suppl. Fig.1). Thus,
human and zebraﬁsh GRb mRNA are generated using different
alternative splicing mechanisms (exon replacement and intron
retention, respectively (van der Vaart and Schaaf, 2009)). A few
years after our discovery of the zebraﬁsh GRb, a GR b-isoform
generated by intron retention was observed in mice as well, and
this isoform appears to play a role in metabolic regulation (Hinds
et al., 2010).
The scope of this study was to investigate the role of zGRb in
gene transcription either as a dominant-negative inhibitor of zGRa
or as a transcription factor independent of zGRa. We have utilized
both in vitro and in vivo approaches. While a dominant-negative
effect of zGRb was observed in reporter assays in cultured cells,
our data did not reveal any dominant-negative activity of zGRb on
endogenous genes in either cultured cells or zebraﬁsh larvae.
Furthermore, we found no convincing evidence for an intrinsic
transcriptional activity of zGRb.2. Materials and methods
2.1. Cell cultures
COS-1 cells were cultured in DMEM (Invitrogen), supplemented
with 10% fetal bovine serum (Invitrogen) and 1% penicillin and
streptomycin (Invitrogen). Cells were grown at 37 C and 5% CO2.
PAC2 zebraﬁsh cells were cultured in Leibovitz's medium (Invi-
trogen), supplemented with 15% fetal bovine serum (Invitrogen)
and 1% penicillin and streptomycin (Invitrogen). Cells were grown
at 28 C.
2.2. Luciferase reporter assays in COS-1 cells
COS-1 cells were seeded into 24-well plates (3  104 cells/well).
Transfection was performed 24 h later using the TransIT®eCOS
Transfection Kit (Mirus Bio) according to the manufacturer's in-
structions. MMTV:luciferase reporter construct (200 ng) was
transfected, with a range of PCS þ zGRa plasmid concentrations
(1e300 ng) and/or 100 ng pCS2þzGRb expression vector (Schaaf
et al., 2008), together with 2 ng pCMV:renilla (Promega). In a sec-
ond set of experiments, cells were transfected with 50 ng of a
kB:luciferase reporter construct (Stratagene) and 50 ng of a human
p65 expression vector (pCMV4-p65 (Ruben et al., 1991)), together
with a range of pCS2þzGRa concentrations (0e1000 ng) in the
presence and absence of 100 ng pCS2þzGRb. The total amount of
transfected DNA was always kept equal among groups by trans-
fecting empty pCS2þ vector. Twenty-four hours after transfection,
cells were treated with 100 nM dexamethasone (Sigma) and 24 h
later, they were assayed for luciferase activity using the Dual-
Luciferase® Reporter Assay System (Promega). Bioluminescence
was detected using a Wallac 1450 MicroBeta Luminometer. For
each sample, the luciferase activity was normalized to the renilla
activity. Per sample, measurements were performed in duplicate,
and data shown are averages ± s. e.m. of three experiments.
2.3. Gene expression analysis using the PAC2-zGRb cell line
The pCS2þzGRb plasmid (Schaaf et al., 2008) and a neomycin
resistance plasmid were transfected into PAC2 zebraﬁsh cells using
the Amaxa® Cell line Nucleofector kit V and the Nucleofector™ II
device (Lonza). Four days after transfection, cells were subjected to
selection for antibiotic resistance by supplementing their culture
medium with 500 mg/ml of geneticin (G418, Invitrogen). Resistant
cells were propagated to establish the PAC2-zGRb cell line. For gene
expression analysis, PAC2 wild type and PAC2-zGRb cells were
seeded in 6-well plates (2  105 cells/well) the day before treat-
ment with 10 mMbetamethasone 17-valerate (Sigma) or vehicle (2%
DMSO) for 3 h. Samples were collected in TRIzol® reagent (Invi-
trogen) and total RNA was isolated following the manufacturer's
instructions (Invitrogen).
2.4. RNA isolation & cDNA synthesis
Total RNA was extracted using the TRIzol® reagent (Invitrogen)
according to the manufacturer's instructions. RNA was dissolved in
water and denatured for 5 min at 60 C. Samples were treated with
DNase using the DNA-free™ kit (Ambion). For microarray analysis,
RNAwas further puriﬁed using the RNeasyMinEluteTM Cleanup kit
from Qiagen and its integrity was checked with a lab-on-a-chip
analysis using the 2100 Bioanalyzer (Agilent Technologies). For
subsequent cDNA synthesis, at least 200 ng of total RNAwas added
as a template for reverse transcription using the iSCRIPTTM cDNA
Synthesis Kit (Biorad).
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qPCR analysis was performed using the MyiQ Single-Color Real-
Time PCR Detection System (Biorad). A detailed description of the
qPCR analysis is provided in the Supplemental.
Methods section. In all qPCR experiments, a non-reverse tran-
scribed sample and a water-control were included. All cDNA sam-
ples were assayed in duplicate. Values shown are means ± s. e.m of
three experiments. Sequences of all primers used for qPCR analysis
are presented in Suppl. Table1.
2.6. Zebraﬁsh strains, husbandry & egg collection
Wild type adult ABxTL zebraﬁsh and the transgenic lines
Tg(hsp70l:Gal4)1.5kca4 ((Scheer et al., 2001) provided by Dr. H. Baier,
University of California, San Francisco, USA) and Tg(UAS:GFP-zGRb)
were used in this study. Livestock was maintained and handled
according to the guidelines from http://zﬁn.org. Fertilization was
performed by natural spawning at the beginning of the light period
and eggs were raised at 28 C in E3 egg water medium containing
60 mg/ml Instant Ocean sea salts supplemented with 0.0025%
methylene blue (GURR). All experimental procedures were con-
ducted in compliance with the directives of the animal welfare
committee of Leiden University.
2.7. The Tg(UAS:GFP-zGRb) transgenic line, heat shock and
glucocorticoid treatment
The generation of the Tg(UAS:GFP-zGRb) line is described in the
Supplemental Methods section. The Tg(hsp70l:Gal4)1.5kca4 and
Tg(UAS:GFP-zGRb) lines were crossed and their offspring were heat-
shocked at 1dpf in Petri dishes ﬁlled with pre-warmed (37 C) E3
egg water medium in a 37 C incubator for 2.5 h. The next day,
embryos were screened for GFP expression and wild types as well
as their GFP expressing siblings were subjected again to the heat
shock protocol. Three-day-old hatched wild types and their GFP
expressing siblings were checked again for GFP signal and treated
with either vehicle (<2% DMSO) or the speciﬁc GR agonist beclo-
methasone (25 mM) for 6 h. Samples were collected in TRIzol® re-
agent (Invitrogen) for subsequent RNA isolation.
2.8. Microarray analysis
A 4  180 k microarray chip platform (customized by Agilent
Technologies, (Design ID:028233)) was used in this study. This
array consists of all probes already present in an earlier 45.219
custom-made array (Stockhammer et al., 2010), and another
126.632 newly designed zebraﬁsh probes had been added as
described in Rauwerda et al., (2010). A total of 16 samples (4
experimental groups from 4 replicate experiments) were processed
for transcriptome analysis. On each 4  180 k slide, 4 samples from
the different experimental groups within the same replicate were
hybridized against a common reference. The microarray was per-
formed and analyzed as described previously (Chatzopoulou et al.,
2015, 2016), and details can be found in the Supplemental Methods
section. The raw data from the microarray experiment were sub-
mitted to the Gene Expression Omnibus database under accession
number GSE84906. Data analysis was performed setting cutoff for
the p-value of <105 and for fold change of either >2 or < -2.
2.9. Gene ontology analysis
As a starting point for the gene ontology analysis of the micro-
array results, clusters of genes were analyzed using the online
functional classiﬁcation tool DAVID (http://david.abcc.ncifcrf.gov/summary.jsp). In addition, for genes not classiﬁed by DAVID, in-
formation was gathered on their function using the websites
GeneCards (http://www.genecards.org/), National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov/gene),
Genetics Home Reference (http://www.ncbi.nlm.nih.gov/gene),
and Wikipedia (http://en.wikipedia.org/wiki/). Using this infor-
mation, all genes were classiﬁed in one of the categories assigned
by DAVID, or in a new category.
2.10. Statistical analysis
Statistical analyses (t-tests and two-way ANOVAs with Bonfer-
roni post-hoc tests) were performed using the GraphPad Prism
version 4.00 (GraphPad Software, La Jolla, USA).
3. Results
3.1. Dominant-negative activity of zGRb in COS-1 cells
Previously, we have demonstrated that zGRb has a dominant-
negative effect on zGRa-mediated transactivation of an MMTV:lu-
ciferase construct in COS-1 cells (Schaaf et al., 2008). In the present
study, we aimed at studying this effect in more detail. First, COS-
1 cells were transiently transfected with an MMTV:luciferase re-
porter construct and a range of zGRa expression vector amounts
with and without cotransfection of a zGRb expression vector. Cells
were incubated with 100 nM dexamethasone (dex) for 24 h and
assayed for luciferase activity. The results show that the luciferase
activity was increased upon increasing concentrations of zGRa
(Fig. 1A). In the presence of zGRb, the luciferase activity was
strongly reduced, even when equal amounts of the zGRa and zGRb
expression vector were transfected. These data demonstrate that
zGRb exhibits a dominant-negative effect on the transcriptional
properties of zGRa on a GRE-containing promoter in these reporter
assays.
In order to study the effect of zGRb on the DNA-binding inde-
pendent activity of zGRa, cells were transiently transfected with a
kB:luciferase construct, an expression vector for the human p65
subunit of the NF-kB transcription factor complex and a range of
zGRa expression vector amounts, with and without cotransfection
of a zGRb expression vector. Cells were incubated with 100 nM dex
for 24 h and assayed for luciferase activity. The results reveal that
with increasing concentrations of zGRa, NF-kB-mediated luciferase
activity was dramatically reduced (Fig. 1B). In these experiments,
the presence of zGRb did not affect the observed luciferase activity
levels, indicating that zGRb does not act as a dominant-negative
inhibitor on the DNA-binding independent activity of zGRa.
3.2. Dominant-negative activity of zGRb in PAC2 cells
In order to study the effect of zGRb on endogenous promoters
in vitro, we generated a PAC2 cell line that stably overexpressed the
zebraﬁsh GR b-isoform (PAC2-zGRb). In PAC2-zGRb cells, the zGRb
mRNA expression level was 260 fold higher than in wild type PAC2
cells (PAC2-wt), whereas the expression of zGRa was not different
between these two cell lines (Fig. 2A and B). That renders zGRb as
the predominant GR splice variant in the PAC2-zGRb line, with a 10-
fold higher absolute mRNA abundance than that of zGRa
(Suppl. Fig.2).
The expression proﬁle of a well-known endogenous GR target
gene, fkbp5 (Schaaf et al., 2009), was investigated upon incubation
with 10 mM betamethasone-17-valerate (BV) by means of qPCR.
Upon BV treatment, a more than 10-fold induction of fkbp5 was
observed in both PAC2-wt and PAC2-zGRb cells. Surprisingly, the
induction of the fkbp5 gene upon BV administration was not
Fig. 1. A. Dominant-negative activity of zGRb on transactivation analyzed by luciferase
assays. COS-1 cells were transiently transfected with an MMTV-luciferase reporter
construct and a range of zGRa expression vector amounts in absence (white bars) and
presence (grey bars) of 100 ng zGRb, and incubated with 100 nM dex for 24 h. The
relative luciferase activity values (setting the 100 ng zGRa transfected group value as
100%) shown are the means ± s. e.m. of three independent experiments. Statistical
analysis by ANOVA revealed an effect of zGRb expression (p ¼ 0.001). Asterisks (*)
indicate a statistically signiﬁcant difference (p < 0.05) from the corresponding control
group (1 ng zGRa). B. Lack of dominant-negative activity of zGRb on repression activity
analyzed by luciferase assays. COS-1 cells were transiently transfected with a kB-
luciferase construct, an expression vector for the human p65 subunit of the NF-kB
transcription factor complex and a range of zGRa expression vector amounts in the
absence (white bars) and presence (grey bars) of 100 ng zGRb plasmid, and incubated
with 100 nM dex for 24 h. The relative luciferase activity values (setting the 0 ng zGRa
transfected group value as 100%) shown are the means ± s. e.m. of three independent
experiments. Statistical analysis by ANOVA demonstrated no signiﬁcant effect of zGRb
expression. Asterisks (*) indicate a statistically signiﬁcant difference (p < 0.05) from
the corresponding control group (0 ng zGRa).
Fig. 2. A. Stable overexpression of the zebraﬁsh GR b-isoform in PAC2 cells. Cells were
stably transfected with a zGRb expression vector for the generation of the PAC2-zGRb
line. The zGRb expression level of this cell line was determined by qPCR. The data show
that the PAC2-zGRb cell line highly overexpresses (>250 fold) the zGR b-isoform
compared to its parental wild type line. Stimulation of both lines with 10 mM BV
(betamethasone-17-valerate) for 3 h did not signiﬁcantly affect zGRb mRNA expres-
sion. B. Expression levels of zGRa mRNA in PAC2-wt and PAC2-zGRb cells treated with
either 10 mM BV or vehicle for 3 h. Statistical analysis by ANOVA demonstrated that
there is no signiﬁcant effect on the expression of the zGR a-isoform due to either BV
treatment or overexpression of the zGR b-isoform. C. Expression levels of fkbp5 mRNA
in PAC2-wt and PAC2-zGRb cells, determined by qPCR. Cells from both lines were
compared for their ability to upregulate the expression of fkbp5 upon treatment with
either 10 mM BV or vehicle for 3 h. Statistical analysis revealed that fkbp5 induction due
to BV treatment does not differ between the two lines examined. In all ﬁgures mRNA
expression measurements were normalized to those of bactin1 and the relative mRNA
concentration values are the means ± s. e.m. of three independent experiments.
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(Fig. 2C). Thus, zGRb does not exhibit any dominant-negative ac-
tivity on zGRa-induced transactivation of the fkbp5 gene in PAC2
cells. Several other known GR target genes (gilz, slc5a1, agtxb,
hsd11b2, pepck, nfkbiaa) were tested for induction upon BV treat-
ment in PAC2 cells as well, but none of these genes showed
increasedmRNA expression, leaving fkbp5 as the only conﬁrmed GR
target gene in these cells.3.3. Generation of a Tg(hsp70l:Gal4/UAS:GFP-zGRb) transgenic line
Subsequently a ﬁsh line was generated in which the zGRb
expression was induced upon a heat shock. We generated a
Tg(UAS:GFP-zGRb) line, containing a construct encompassing a
cDNA encoding a GFP-tagged zGRb positioned downstream of a14xUAS promoter that is activated by the Gal4 transcription factor.
This line was crossed with the Tg(hsp70l:Gal4)1.5kca4 line (in which
Gal4 expression is controlled by a heat shock-inducible promoter),
yielding the Tg(hsp70l:Gal4/UAS:GFP-zGRb) line. Embryos from this
line at 1 and 2 day post fertilization (dpf) were heat shocked and
the GFP signal was readily detectable within a few hours. Expres-
sionwas clearly present in cells in themuscles and eyes, and in cells
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suggested that GFP-zGRb is localized in the nuclei of the cells
(Fig. 3C), which was conﬁrmed by co-staining with Sytox Orange
(data not shown).
In order to conﬁrm that the fusion protein was properly
expressed, qPCR analysis showed that in the ﬂuorescent larvae GRb
mRNA levels were increased 22-fold compared to non-ﬂuorescent
(wild type) larvae (Suppl. Fig.3). Using a previously characterized
expression vector for YFP-tagged zGRb (Schaaf et al., 2008), we
showed in COS-1 cells that this type of tag does not affect zGRb’s
dominant-negative activity (Suppl. Fig.4).3.4. Microarray analysis of zGRb activity using the Tg(hsp70l:Gal4/
UAS:GFP-zGRb) line
Next it was explored at the whole transcriptome level whether
zGRb plays a functional role in transcriptional regulation, using a
custom-designed microarray platform (Rauwerda et al., 2010). The
Tg(hsp70l:Gal4)1.5kca4 line was crossed with the Tg(UAS:GFP-zGRb)
line. The resulting embryos were identiﬁed, upon heat shock, based
on the observed ﬂuorescence as either wild type (lacking ﬂuores-
cence, referred to as WT) or GFP-zGRb-overexpressing (showing
green ﬂuorescence, referred to as GRb). Both populations were
treated with either 25 mM beclomethasone (beclo) or vehicle (veh)
for 6 h at 3dpf. Thus, 4 groups were generated: WT/veh, WT/beclo,
GRb/veh, GRb/beclo (Fig. 4A). Total RNA samples from 4 biological
replicates (16 samples in total) were processed for the microarray
study using a common reference design. Data were analyzed using
Rosetta Resolver 7.2 software, setting signatures for signiﬁcantly
regulated probes at a p-value cutoff of p < 105 and fold changes
either >2 or < -2.
As a ﬁrst step, we studied genes regulated upon beclo treatment
in the wild type ﬁsh (comparison WT/veh vs. WT/beclo). We
identiﬁed 2508 probes corresponding to genes signiﬁcantly regu-
lated by beclo treatment (1805 up, 703 down). Of these probes,
1592 could be attributed to an annotated gene, yielding a total of
907 genes identiﬁed as beclo-regulated. For 13 randomly chosen,
validation by qPCR was performed, and a signiﬁcant effect of beclo
treatment was conﬁrmed for all genes tested (Suppl. Fig.5). Gene
ontology analysis showed that 137 genes in this cluster were
involved in metabolic processes, of which 38 in the metabolism of
carbohydrates, 37 in protein metabolism, and 18 in lipid meta-
bolism. Other gene ontology groups overrepresented in this cluster
were those containing genes involved in membrane transport (67
genes), genes encoding transcription factors (58), and genesFig. 3. Images of a 3dpf zebraﬁsh embryo generated by crossing the Tg(hsp70:Gal4) and Tg(
2dpf. A. Transmitted light microscopy image showing representative embryo, indicating t
embryos. B. Fluorescence microscopy image showing expression of the GFP-zGRb fusion pro
and in cells lining the yolk sac. C. Larger magniﬁcation ﬂuorescence microscopy image sh
localized in the nuclear cell compartment.involved in cell cycle and apoptosis (49). An overview of the gene
ontology analysis of this cluster is presented in Fig. 4B, and detailed
information is presented in Suppl. Table2.
In order to examine a dominant-negative effect of zGRb, we
studied the effect of zGRb overexpression on gene regulation upon
beclo administration. For this purpose, the level of regulation by
beclo after GFP-zGRb overexpression (comparison GRb/veh vs. GRb/
beclo) was plotted against the regulation by beclo without GFP-
zGRb overexpression (comparison WT/veh vs. WT/beclo), for all
probes signiﬁcantly regulated in at least one of these comparisons
(Fig. 5A). The resulting scatter plot shows that generally gene
regulation by beclo is not different between these two conditions.
Thus, this analysis shows no evidence for a dominant-negative
activity of zGRb on zGRa-mediated gene transcription induced by
beclo. Since GFP-GRb overexpression levels were particularly high
inmuscle cells (Fig. 3), a similar plot wasmade using only data from
probes corresponding to genes involved in muscle function and/or
muscle development (Suppl. Fig.6), showing a similar lack of evi-
dence for a dominant-negative effect.
To study a possible dominant-negative activity of zGRb more
speciﬁcally, regulation for all 2508 probes regulated by beclo was
compared between the WT/beclo and the zGRb/beclo group. Of the
1805 probes corresponding to beclo-upregulated genes, 30 genes
showed a downregulation upon overexpression of zGRb (in the
presence of beclo). These data indicate a dominant-negative effect
of zGRb (Fig. 5B). In addition, for 35 of the 703 probes corre-
sponding to genes downregulated by beclo treatment, an upregu-
lation was observed upon overexpression of zGRb (in the presence
of beclo), also indicating a dominant-negative effect of zGRb
(Fig. 5C). Thus, in our microarray experiment, a signiﬁcant inhibi-
tory activity of zGRb on zGRa-induced transcriptional regulation
was detected for 65 probes, which accounts for 2.6% of all beclo-
regulated probes. Within the cluster of 65 probes that indicated a
dominant-negative activity of zGRb, 31 probes could be attributed
to 29 genes. Eight randomly chosen genes from this cluster were
used for validation of the microarray results by qPCR. In this vali-
dation, we could not verify any signiﬁcant zGRb dominant-negative
effect on any of the genes tested (Suppl. Fig.7).
Finally, we investigated whether zGRb has intrinsic transcrip-
tional activity, able to regulate the expression of target genes
independently of zGRa activity. For that reason, we compared the
WT/veh and GRb/veh groups and we identiﬁed 258 probes corre-
sponding to up-regulated transcripts due to the zGRb over-
expression and 223 probes corresponding to down-regulated ones.
These 481 regulated probes be attributed to 193 annotated genes.UAS:GFP-zGRb) transgenic lines. Embryos were heat shocked at 37 C for 2.5 h at 1 and
hat transgenesis and heat shock treatment do not alter the morphology of zebraﬁsh
tein. The green ﬂuorescent signal is clearly present in cells in the muscles and the eyes,
owing expression of GFP-zGRb in muscle tissue. The image shows that GFP-zGRb is
Fig. 4. A. Schematic overview of microarray analysis and subsequent qPCR validation of beclo and GRb effects using a 180 k zebraﬁsh microarray platform. The Tg(hsp70:Gal4) line
was crossed with the Tg(UAS:GFP-zGRb) line and the resulting embryos were heat shocked at 37 C for 2.5 h at 1 and 2dpf. At 3dpf, embryos were sorted based on their GFP signal
and treated with 25 mM beclo for 6 h. Thus, 4 groups were generated: WT/veh, WT/beclo, GRb/veh, GRb/beclo. Total RNA samples were processed for transcriptome analysis by
microarray. Results for beclo-as well as GRb-mediated effects on transcription were analyzed using Rosetta Resolver 7.2 software. Probes were found to be signiﬁcantly different at a
p-value cutoff of p < 105 and fold changes either >2 or < -2. B. Gene ontology groups represented in the clusters of beclo-regulated genes. The results show that beclo mainly
regulated genes involved in metabolism. Details on individual genes are presented in Suppl. Table2.
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factors (18) and genes involved in metabolism (17) were over-
represented, as well as genes involved in DNA/RNA processing, (11),
membrane transport (10) and the nervous system (10). An over-
view of the gene ontology analysis of this cluster is presented in
Fig. 6A, and detailed information is presented in Suppl. Table3.
These overrepresented gene ontology groups are clearly different
from the groups overrepresented in the beclo-regulated cluster
(Fig. 4), and further comparison between these clusters shows that
from the 481 probes regulated upon GFP-zGRb overexpression,
only 76were also in the cluster of genes regulated by beclo (Fig. 6B).
These data indicate that GFP-zGRb regulates a different cluster of
genes than beclo, which is further demonstrated in a scatter plot in
which the regulation upon GFP-zGRb overexpression is plotted
against the regulation upon beclo administration for all probes
regulated by at least one of these treatments (Suppl. Fig.8). Fromthe cluster of 193 genes, 10 randomly selected genes were used for
validation. Again, qPCR analysis failed to verify any signiﬁcant zGRb
effect on any gene tested (Suppl. Fig.9).
Validation by qPCR failed for the regulation of genes due to GFP-
zGRb overexpression (dominant-negative or intrinsic transcrip-
tional activity), whereas gene regulation due to beclo treatment
was conﬁrmed in all cases studied. This prompted us to further
investigate differences between the clusters of beclo- and zGRb-
regulated genes. We found that a more stringent analysis of the
microarray data dramatically decreases the size of the clusters of
zGRb-regulated genes, whereas it has amuch smaller impact on the
cluster of beclo-regulated ones. For example, using a signiﬁcance
threshold of p ¼ 1010, instead of p ¼ 105 as done in this study,
zGRbwould show a dominant-negative effect on only 17% of the 65
probes found at p¼ 105 and an intrinsic transcriptional activity on
only 22% of the 105 probes found at p ¼ 105. In contrast, beclo
Fig. 5. Analysis of a possible dominant-negative activity of GFP-GRb. A. Scatter plot
showing the level of gene regulation upon beclo treatment (WT/veh vs WT/beclo)
plotted against regulation of genes by beclo treatment after GFP-zGRb overexpression
(GRb/veh vs GRb/beclo). Data points indicate levels for individual probes. Data are
shown for probes that were signiﬁcantly regulated at least 2-fold by one or both of
these treatments. The plotted line indicates points where beclo regulation without GRb
overexpression equals beclo regulation upon GRb overexpression. The scatter plot
shows that generally beclo regulates gene expression after similarly to regulation with
and without GRb overexpression, so this analysis shows no evidence for a general
dominant-negative activity of zGRb on zGRa-mediated gene regulation. B. Venn dia-
gram showing the cluster of genes of which the beclo-induced upregulation is atten-
uated by GRb. This cluster is represented by the overlap between the cluster of genes
upregulated by beclo (WT/beclo > WT/veh, grey circle) and the cluster of genes
downregulated by GFP-zGRb overexpression in the presence of beclo (GRb/
beclo <WT/beclo, green circle). C. Venn diagram showing the cluster of genes of which
the beclo-induced downregulation is attenuated by GRb, represented by the overlap
between the cluster of genes downregulated by beclo (WT/beclo <WT/veh, grey circle)
and the cluster of genes upregulated by GFP-zGRb overexpression in the presence of
beclo (GRb/beclo > WT/beclo, green circle). (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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p ¼ 105. Alternatively, limiting the analysis to genes that show
regulation for at least two probes would have left very few zGRb-
regulated genes (2 for zGRb dominant-negative activity and 4 for
zGRb intrinsic transcriptional activity), whereas still a signiﬁcant
number of beclo-regulated probes (302) would have been found.
This shows that the relative number of false-positives among the
zGRb-regulated genes is considerably larger than among the beclo-
regulated genes, which was reﬂected in the data of our qPCR
validation.
4. Discussion
In the present study we have used the zebraﬁsh as a model
organism to investigate the regulatory role of the zebraﬁsh GR b-
isoform in gene transcription. We initially looked at its dominant-
negative effect on the transcriptional properties of the GR a-iso-
form. By means of luciferase reporter assays using transient
transfections in COS-1 cells we demonstrated that zGRb strongly
inhibits zGRa’s transcriptional activity on a GRE-containing pro-
moter, evenwhenwe transfected equal amounts of zGRa and zGRb
expression vectors. This dominant-negative activity had already
been observed in our laboratory using a 1:10 zGRa/zGRb ratio.
(Schaaf et al., 2008). It recapitulates data obtained in similar
reporter assays in which the human GRb (Bamberger et al., 1995;
Charmandari, 2004; Oakley et al., 1999; Yudt et al., 2003) and
mouse GRb (Hinds et al., 2010) showed a dominant-negative effect
at 1:10 and 1:2 a/b transfection ratio, respectively. In contrast, we
did not observe an effect of zGRb on the ability of zGRa to repress
NF-kB activity in an in vitro reporter assay. The speciﬁcity of the
dominant-negative activity of GRb for the DNA-binding dependent
transcriptional activity of GRa has also been shown for the human
GR b-isoform in numerous studies in which similar sets of experi-
ments were performed (Bamberger et al., 1997; Gougat et al., 2002;
Kelly et al., 2008; Kim et al., 2009), even at a 1:20 a/b transfection
ratio in COS-7 cells (Brogan et al., 1999). In contrast, one study has
demonstrated a speciﬁc dominant-negative effect of hGRb on the
hGRa-induced repression of gene regulation by NF-kB and CREB
(Taniguchi et al., 2010) and a dominant-negative effect on the dex-
induced repression of TNFa and IL6 expression was demonstrated
in human monocytes (Li, 2006).
We next addressed the question whether zGRb also exhibits
dominant-negative properties on the zGRa-induced transactivation
of endogenous genes. From studies in human cell cultures there is a
solid body of evidence that hGRb inhibits hGRa-induced activation
of a number of endogenous genes (Goleva et al., 2006; Kino et al.,
2009a,b; Li, 2006; Zhang, 2005). In the present study, we gener-
ated a PAC2 cell line that stably overexpressed zGRb. Surprisingly,
we did not observe any effect of zGRb overexpression on the zGRa-
induced activation of fkbp5 gene (a well-known GRa target gene (U
et al., 2004)). Thus, it appears that zGRb does not exhibit a general
dominant-negative activity on zGRa-induced gene activation.
Interestingly, recent studies in mice reported a lack of GRb over-
expression effect on GRa-induced fkbp5 transcription, whereas a
dominant-negative activity on other, mostly metabolism-related
genes, was observed (Hinds et al., 2010). Unfortunately, due to a
limited responsiveness of our PAC2 line to GC treatment, we were
not able to assess the zGRb inhibitory effect on other GRa target
genes.
In order to get a genome-wide view of zGRb’s transcriptional
properties, we performed a transcriptome analysis upon zGRb
overexpression in vivo. We generated the Tg(hsp70:Gal4/UAS:GFP-
zGRb) transgenic line. Using this in vivo transgenic model combined
with a microarray approach, we initially found an effect of zGRb
overexpression on 481 probes (independent of zGRa activity), and
Fig. 6. A. Gene ontology groups represented in the clusters of GRb-regulated genes. The results show that GFP-zGRb overexpression mainly regulated genes encoding transcription
factors and genes involved in metabolism. Details on individual genes are presented in Suppl. Table3. B. Venn diagram showing the overlap between the cluster of genes regulated
by GFP-GRb overexpression (GRb/veh vs WT/veh) and beclo (WT/beclo vs WT/veh, green circle). (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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after careful analysis of the microarray data we concluded that at
least the vast majority of these data represent false positive results.
The distributions of p-values and number of probes per gene
showing regulation within the subsets of zGRb-regulated genes
was remarkably different from those found for the cluster of probes
showing regulation by beclo treatment, raising questions about the
conﬁdence level of the results on zGRb regulation. Indeed, using
qPCR analysis of a set of genes showing regulation by zGRb in the
microarray we could not verify the effect of zGRb on any of the
selected genes. Using qPCR on genes showing regulation by beclo
we could verify the results from the microarray on all selected
genes, supporting the validity of our study.
These results led us to suggest that the effects of zGRb on
transcription in our transgenic zebraﬁsh model are absent. Com-
bined with the negative results obtained in PAC2 cells, our ﬁndings
generally lack evidence for a transcriptional role for zGRb. These
data are in linewith our previous in vivowork on zGRb, inwhichwe
overexpressed this receptor isoform by injection of mRNA and a
splice-blocking morpholino (Chatzopoulou et al., 2015). The results
of this study showed no evidence for a dominant-negative activity,like the results of the present study. In addition, both the GRb
mRNA and the morpholino injection affected a cluster of genes,
independent of zGRa activity (149 and 485 genes respectively). The
overlap between these two clusters was small (13 genes), and
overlap with the cluster of 193 genes regulated by GFP-GRb in the
present study was even smaller (3 and 5 genes respectively). Taken
together, the inconsistency between the different studies suggests
that the observed effects on gene expression gene were either
nonspeciﬁc or off-target effects of the treatment or false-positive
results. Furthermore, the studies on the zGR b-isoform presented
here demonstrate that dominant-negative activity observed in re-
porter assays does not necessarily imply a similar effect on
endogenous genes in vivo. This discrepancy probably originates
from endogenous gene sequences being embedded in chromatin,
which may make them less accessible to DNA-binding factors like
GRb than transiently transfected DNA constructs.
Recent transcriptome analyses have revealed that the vast ma-
jority of genes in vertebrate genomes are subject to alternative
splicing, and that alternatively spliced mRNA isoforms are highly
species-speciﬁc (Barbosa-Morais et al., 2012). Apparently, the
alternative usage of exons changes rapidly during evolution.
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the expression of GRb in zebraﬁsh is restricted to a relatively small
group of ﬁsh (Schaaf et al., 2008), and that this is commonly
observed for C-terminal splice variants of nuclear receptors (van
der Vaart and Schaaf, 2009). Analysis of a variety of ﬁsh genomes
(Suppl. Fig.10) demonstrated that important changes occurred in
the organization of the GR gene after the Ostariophysii superorder
(towhich the zebraﬁsh belongs) branched off the lineage that led to
the Acantopterygii (110e160 million years ago). The sequence of
the splice donor site at the 3'end of exon 8 changed signiﬁcantly
and the length of intron 8 increased dramatically. These alterations
did not immediately lead to a weak splice donor site and intron
retention, but were most likely ﬁrst steps towards enabling further
evolution towards GRb expression in zebraﬁsh and possibly in
other species.
The lack of an effect of the GR b-isoform in zebraﬁsh presented
in this study follows the trend of controversy over the physiological
function of the GR b-isoform in humans. After more than 20 years
of research, a consistent view on a possible dominant-negative
activity in vivo is still lacking. The observations on the intrinsic
transcription factor activity of hGRb (Kino et al., 2009a,b; Lewis-
Tufﬁn et al., 2007) have recently added more inconsistent data,
since a large set of genes appeared to be oppositely regulated by
hGRb in different studies (Kino et al., 2009a,b). Although our work
on the functional role of GRb in zebraﬁsh does not support a
transcriptional role for this GR isoform, we would like to be careful
with extrapolating these results to the human situation, since the
role of the human GR b-isoform may be different.
5. Conclusions
Taken together, our data indicate that zGRb does not have a
functional role in transcriptional regulation, although effects on a
small subset of genes or effects highly speciﬁc for a certain tissue or
condition can not be ruled out. Splicing of a GR pre-mRNA into a
messenger encoding GRb could be a physiological way to down-
regulate the levels of GRa. In such a case, the GR b-isoform does not
have an active inhibitory role but the generation of mRNA encoding
this splice variant would result in a decreased expression of the
canonical GR a-isoform, thereby lowering the activity of the GC
signaling pathway.
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